13 – 15 August 2018 Adelaide Convention & Exhibition Centre

International Keynote Speakers

 

More to be confirmed!

 

SpeakerBiography
Mehlika Toy
Stanford University, USA

Mehlika Toy, Ph.D., is a research scientist at Stanford University. Her research focuses on developing decision models, assessment of potential impact, and cost-effectiveness analysis on chronic hepatitis B infection management. She has developed decision models to help policy making in the Netherlands, Turkey, China and the United States and is continuing to develop models to help countries with their national policies in chronic hepatitis B infection control. Dr. Toy completed her Ph.D. in Public Health at Erasmus University and was a Takemi Fellow in International Health at Harvard University. She serves as a member of the World Health Organization’s Strategic Information and Viral Hepatitis Modeling Reference Group.
Speaker Biography
Andrew Lloyd
The Kirby Institute, UNSW SYDNEY

Professor Andrew Lloyd is an infectious diseases physician and immunovirology researcher at the Kirby Institute. He is an NHMRC Practitioner Fellow. Over many years in conjunction with the Justice health & Forensic Mental Health Network, he has led the development of the Hepatitis Service in the NSW prisons. He was awarded an Australia Medal (AM) for this work, and for his research achievements in infectious diseases.